Abstract:Tuberculosis(TB) is a zoonotic disease caused by Mycobacterium tuberculosis complex group.Approximately one third of the world's population is currently infected with tuberculosis, but only 10% of infection further developing tuberculosis. The animal tuberculosis not only causes heavy economic losses to the livestock industry, but also is an important source of human tuberculosis. BCG is currently the only licensed vaccine for prevention of children tuberculosis, but it has some drawbacks. A variety of novel TB vaccines have been reported,such as recombinant BCG, novel attenuated live vaccines, subunit vaccines, DNA vaccines, live viral vector vaccines, some of which have entered into different stages of human clinical trials. However the research on animal tuberculosis vaccine has just started. Badger BCG vaccine is the first licensed animal TB vaccine. Other animal vaccines against tuberculosis for cattle, deers, and possums are being studies. However, there is no commercial novel TB vaccine to replace BCG. Therefore, there is still a long way to go for the research on development and application of novel vaccines against tuberculosis for both humans and animals.

Progress on Development and Application of Novel Tuberculosis Vaccine